High-Quality Moclobemide Pharmaceutical Intermediate: Purity, Applications, and Supplier Information
Discover the key benefits and applications of this vital intermediate for mental health treatments.
Get a Quote & SampleProduct Core Value
Moclobemide Pharmaceutical Intermediate Powder
As a leading pharmaceutical intermediate, Moclobemide powder is crucial for synthesizing advanced antidepressants and treatments for social anxiety. It functions as a selective, reversible inhibitor of monoamine oxidase A (RIMA), offering a more favorable side effect profile compared to older antidepressant classes.
- High purity 99% Moclobemide pharmaceutical intermediate powder ensures reliable synthesis of active pharmaceutical ingredients.
- The key CAS 71320-77-9 chemical structure makes it an indispensable component in modern psychiatric drug development.
- This reversible MAOI intermediate offers a better safety profile, particularly for elderly patients and those with cardiovascular issues, unlike traditional MAOIs.
- The ability to improve mood and cognitive function makes it a sought-after antidepressant raw material price point for manufacturers globally.
Key Advantages
Superior Tolerability
Experience improved patient compliance due to Moclobemide's better tolerability and fewer adverse effects compared to tricyclic antidepressants, a crucial factor when sourcing for bulk pharmaceutical needs.
Enhanced Safety Profile
Benefit from a reduced risk of hypertensive crisis, making it a safer alternative for patients, a key consideration for research into effective antidepressant raw material price points.
Broad Therapeutic Efficacy
Utilize this versatile intermediate for a range of mental health conditions, including major depressive disorder and social phobia, ensuring broad market applicability.
Key Applications
Antidepressant Manufacturing
Production of effective treatments for depression, leveraging its RIMA properties for a cleaner pharmacological profile.
Social Anxiety Disorder Therapy
Development of medications to manage social anxiety, supported by clinical trial data highlighting its efficacy.
Pharmaceutical Research & Development
Essential for R&D in neuropharmacology, exploring new therapeutic avenues for mental health conditions.
API Synthesis
A core component in the synthesis of Active Pharmaceutical Ingredients (APIs), ensuring high standards of purity and consistency.